Financial Times: Buy-out groups in $850m HGI deal Goldman Sachs Capital Partners and Clayton, Dubilier & Rice will acquire the provider of mail-order medical products from the Chicago-based Jordan Company and the Harrington family Financial Times: Medical City in Manila lures foreign clients The 800-bed hospital complex in Manila does not have the look and feel of a place for the sick, and it is at the forefront of the country's attempt to become a medical tourism hub Financial Times: Sanofi in approach to Genzyme The French pharmaceuticals group has made a preliminary approach to the US biotech company that has built its business on high-price drugs used to treat rare conditions Financial Times: GlaxoSmithKline falls into the red Pre-tax loss of £97m in the second quarter follows fresh legal charges and further restructuring at the UK's biggest drug company to cover a cut in its US sales force Financial Times: HIV gel research lifts spirits Until now abstinence and the use of condoms have remained the safest ways to avoid sexually transmitted infections, and data suggest male circumcision could significantly cut the risk of HIV infection Financial Times: Industry drools over China's dieting urge The merest glance at a WeightWatchers meeting in China makes clear that a model that works in the American cornbelt cannot be transplanted wholesale to Asia. Chinese dieters are just not fat enough Financial Times: Castellani to lead US drug association A prominent Republican business lobbyist is named the head of Pharmaceutical Research and Manufacturers ofAmerica, a trade group that played a critical role in the passage of the US healthcare reform bill Financial Times: Key questions trouble Treasury How will GPs be held accountable for £70bn of public money, and what happens if a purchasing consortium goes bust? Both are key questions the NHS white paper has to answer Financial Times: Doctors dispense cure for overspent Cumbria Peter Weaving and his colleagues in Cumbria are alreadyoffering a glimpse into what the coalition government's healthcare revolution could look like Financial Times: GPs to run £70bn NHS spending in power shift Family doctors are to be given control of £70bn of National Health Service expenditure with which to buy patient care in the biggest single transfer of power and accountability in the NHS's 60-year history US health insurance trusts US health insurance trusts Parkway hospitals AstraZeneca

Financial Times - Companies - Drugs & Healthcare Financial Times - Companies - Drugs & Healthcare View source archive --> Search this source --> ·AstraZeneca doubles share buy-back plan Astra Zeneca upgrades earnings forecasts following strong US expert endorsement of its new drug Brilinta ·Buy-out groups in $850m HGI deal Goldman Sachs Capital Partners and Clayton, Dubilier & Rice will acquire the provider of mail-order medical products from the Chicago-based Jordan Company and the Harrington family ·Medical City in Manila lures foreign clients The 800-bed hospital complex in Manila does not have the look and feel of a place for the sick, and it is at the forefront of the country's attempt to become a medical tourism hub ·India's Apollo tackles MS frontiers Apollo Hospitals is offering 'Liberation Therapy' – an unorthodox treatment aimed at improving blood supply to the brain of people suffering from multiple sclerosis ·Seoul group finds stem-cell niche STC Life is trying to become a niche player in Asia's burgeoning medical tourism market with its advanced technology in stem-cell treatment for terminal diseases ·Taiwan courts Chinese patients Lion Travel hopes to become a big presence in the medical tourism sector by attracting Chinese tourists to the island as old barriers to travel across the Taiwan Strait fall ·Khazanah trumps Fortis in Parkway battle Malaysian state investor Khazanah has trumped India's Fortis Healthcare in a takeover battle for Singapore's Parkway Holdingswith a bid that values the company at about S$4.5bn ·Asia is hot destination for medical tourists The tussle for Singapore's Parkway Holdings healthcare group demonstrates the high value attached by the rival bidders to Parkway's extensive hospital network, which the bidders hoped to use to create a leading Asian healthcare provider – and capitalise on the region's fast-growing medical tourism industry ·Sanofi makes approach to Genzyme The French pharmaceuticals group has made a preliminary approach to the US biotech company that has built its business on high-price drugs used to treat rare conditions ·Roche plays down US bar on cancer drug Swiss drugmaker tries to limit the impact of a US regulatory panel's recommendation to restrict one of its key cancer drugs as it reports strong second-quarter results

BNET: Company Updates: Medco Health Solutions Inc. Latest updates from BNET. View source archive --> Search this source -->

BNET: Company Updates: UnitedHealth Group Inc. Latest updates from BNET. View source archive --> Search this source -->

View category archive -->
Search this category -->